Latest Breast Cancer News

Combo Of Heat Shock Protein Inhibitor And Hormonal Therapy Being Tested In Breast Cancer Clinical TrialPushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this system, heat shoc...

Breast Cancer Risk Associated With Sex Hormones Reduced By Losing WeightThe Journal of Clinical Oncology has published a study online which reveals that even a moderate amount of weight loss can considerably decrease levels of circulating estrogens that are linked to a higher risk of breast cancer. Anne McTiernan, M.D.,...

Fitness May Boost Survival for Women With Breast CancerFRIDAY, May 25 -- Women with advanced breast cancer who have higher levels of fitness during treatment tend to live longer than women with lower levels of fitness during treatment, new research finds. Treatments for breast cancer can weaken women's.....

Chugai seeks Japanese approval for pertuzumabChugai Pharmaceutical Co. Ltd. (Tokyo:4519) said it submitted an NDA to the Japanese Ministry of Health, Labor and Welfare (MHLW) for pertuzumab to treat HER2-positive metastatic or recurrent breast cancer. Chugai, which is majority owned by Roche (S...

Pertuzumab filed for breast cancer in JapanRoche's subsidiary Chugai has made an approval filing in Japan for Genentech/Roche's HER-dimerisation inhibitor pertuzumab, for the treatment of HER2-positive metastatic or recurrent breast cancer. The submission incorporates data from the.....

Roche submits pertuzumab to Japan health bodyZURICH, May 25 (Reuters) - Roche's Japanese subsidiary Chugai said on Friday it had submitted Roche's experimental breast cancer drug to Japanese health authorities for approval.

Poor cardio-pulmonary function may be strong predictor of survival in women with breast cancerWomen receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical Center.

Millennium and Takeda Announce Presentations for Key Investigational Molecules at American Society of Clinical Oncology Annual Meeting- Presentations highlight first oral proteasome inhibitor in clinical trials in multiple myeloma patients -CAMBRIDGE, Mass., May 23, 2012 – with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced that 101 abstracts featuring the Company’s oncology molecules have been accepted at the annual meeting of the American Socie...

Chemotherapy's Effectiveness May Be Predicted By Breast MRIMagnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online in the journal Radiology. Wo...

Hazelnuts improve infant formula(University of Georgia) Human breast milk is the best source of food for infants. University of Georgia researchers have found what may be a new second best -- formula made from hazelnut oil.

Breast Cancer Patients' Survival Influenced By Their Cardio Fitness LevelsWomen receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical Center. The findings, repor...

Celldexs CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer ...

Celldex?s Cdx-011 Demonstrates High Response Rates in Patients With Metastatic Breast Cancer Expressing Elevated Levels of Gpnmb and in Triple Negative Disease--Webcast scheduled for 4:30 pm ET today-- NEEDHAM, MA (May 23, 2012): Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced preliminary results from the Company’s randomized Phase 2b EMERGE study of CDX-011 (glembatumumab...

Lower Risk Of Psoriasis Linked WIth Physical ActivityA study of American women published in Archives of Dermatology shows that energetic, physical activity could be linked to a reduced risk of psoriasis, a chronic inflammatory skin disorder that redness, irritation and scaling. According to the resea...

Celldex's CDX-011 EMERGEs as advantageous targeted option in advanced breast cancerCelldex Therapeutics said 32% of breast cancer patients whose tumours express high levels of glycoprotein NMB (GPNMB) responded to the company's CDX-011 (glembatumumab vedotin) immunotherapy in a randomised Phase IIb study that also identified a.......

The landscape of genes mutated in breast cancer

Celldex's CDX-011 shows promise in breast cancer trialA Phase II study found Celldex Therapeutics' experimental drug CDX-011 more effective than standard chemotherapy in reducing -More-

Side Sleeper Pillow Discovers Social MediaComfort Quest expands exposure on Facebook, Twitter, LinkedIn, and Pinterest. Agoura Hills, CA (PRWEB) May 24, 2012 Comfort Quest, Inc., manufacturer of the Side Sleeper Pillow designed to help women manage their pain and sleep well after all types of chest surgery, announced it has expanded its presence in social media sites such as Facebook, Twitter, LinkedIn, and Pinterest. The Side Sleeper Pi...

Halo Healthcare acquires assets of NeoMatrixHalo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breas...

Preliminary results from Celldex’s CDX-011 Phase 2b breast cancer studyCelldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pret...

Antibody-drug conjugate shrinks some breast cancer tumors-study

Sientra’s “Stand-By” Series C Shows How To Eliminate Late-Stage RiskBreast-implant start-up Sientra recently raised a $65 million Series C round at a time when venture capital for medtech is scarce, particularly for mid-stage companies pushing toward important milestones. Using a new kind of “stand-by” financing,...

International study finds cardio fitness levels of breast cancer patients may affect survivalWomen receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical Center. The findings, repor...

Innovative Computer Modeling Techniques Enable Creation Of New Anti-Cancer DrugA team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many ty...

Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease--Webcast scheduled for 4:30 pm ET today-- NEEDHAM, Mass.--(BUSINESS WIRE)--May 23, 2012 - Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab.....

0 1 2 3 4 ›»

buy Breast Cancer market research data and corporate reports now Advertisement